Suppr超能文献

G蛋白偶联受体工程为β2肾上腺素能受体功能带来了高分辨率的结构见解。

GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.

作者信息

Rosenbaum Daniel M, Cherezov Vadim, Hanson Michael A, Rasmussen Søren G F, Thian Foon Sun, Kobilka Tong Sun, Choi Hee-Jung, Yao Xiao-Jie, Weis William I, Stevens Raymond C, Kobilka Brian K

机构信息

Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305, USA.

出版信息

Science. 2007 Nov 23;318(5854):1266-73. doi: 10.1126/science.1150609. Epub 2007 Oct 25.

Abstract

The beta2-adrenergic receptor (beta2AR) is a well-studied prototype for heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) that respond to diffusible hormones and neurotransmitters. To overcome the structural flexibility of the beta2AR and to facilitate its crystallization, we engineered a beta2AR fusion protein in which T4 lysozyme (T4L) replaces most of the third intracellular loop of the GPCR ("beta2AR-T4L") and showed that this protein retains near-native pharmacologic properties. Analysis of adrenergic receptor ligand-binding mutants within the context of the reported high-resolution structure of beta2AR-T4L provides insights into inverse-agonist binding and the structural changes required to accommodate catecholamine agonists. Amino acids known to regulate receptor function are linked through packing interactions and a network of hydrogen bonds, suggesting a conformational pathway from the ligand-binding pocket to regions that interact with G proteins.

摘要

β2肾上腺素能受体(β2AR)是一种研究充分的异源三聚体鸟嘌呤核苷酸结合蛋白(G蛋白)偶联受体(GPCR)的原型,这类受体可对可扩散激素和神经递质作出反应。为克服β2AR的结构灵活性并促进其结晶,我们构建了一种β2AR融合蛋白,其中T4溶菌酶(T4L)取代了GPCR大部分的第三个细胞内环(“β2AR-T4L”),并表明该蛋白保留了接近天然的药理学特性。在已报道的β2AR-T4L高分辨率结构背景下,对肾上腺素能受体配体结合突变体的分析为反向激动剂结合以及容纳儿茶酚胺激动剂所需的结构变化提供了见解。已知调节受体功能的氨基酸通过堆积相互作用和氢键网络相连,这表明了一条从配体结合口袋到与G蛋白相互作用区域的构象途径。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验